Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Hims & Hers Health Inc’s stock clocked out at $56.33, up 6.75% from its previous closing price of $52.77. In other words, the price has increased by $6.75 from its previous closing price. On the day, 41.47 million shares were traded.
Ratios:
To gain a deeper understanding of HIMS’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 39.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 53.59. For the most recent quarter (mrq), Quick Ratio is recorded 1.32 and its Current Ratio is at 1.59. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on June 04, 2025, Reiterated its Buy rating but revised its target price to $65 from $61 previously.
On April 29, 2025, TD Cowen Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $30.
Morgan Stanley Downgraded its Overweight to Equal-Weight on February 18, 2025, whereas the target price for the stock was revised from $42 to $60.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 06 ’25 when Chi Michael bought 5,100 shares for $56.00 per share.
Melissa Baird bought 33,333 shares of HIMS for $1,786,982 on Jun 04 ’25. On May 28 ’25, another insider, Okupe Oluyemi, who serves as the Chief Financial Officer of the company, sold 11,581 shares for $52.98 each. As a result, the insider received 613,537 and left with 39,153 shares of the company.
Valuation Measures:
As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 81.99, and their Forward P/E ratio for the next fiscal year is 59.03. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.37. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.07 while its Price-to-Book (P/B) ratio in mrq is 22.93.
Stock Price History:
Over the past 52 weeks, HIMS has reached a high of $72.98, while it has fallen to a 52-week low of $13.47. The 50-Day Moving Average of the stock is 34.48%, while the 200-Day Moving Average is calculated to be 79.41%.
Shares Statistics:
A total of 215.21M shares are outstanding, with a floating share count of 200.63M. Insiders hold about 10.37% of the company’s shares, while institutions hold 70.31% stake in the company.
